IL1B and Hyperglycemia: Treatment of hMCs with IL-1β in 5 mmol/L glucose media led to a 2.38 ± 0.6 fold increase in RIP2 protein levels (Figure 4B) demonstrating that both stimuli, hyperglycemia and IL-1β, upregulate the expression of RIP2.